Health Condition 1: N72- Inflammatory disease of cervix uteri
Conditions
Interventions
Intervention1: Local Unani formulation: Murdar sang-Monoxide of Lead 1g Geru-Silicate of Alumina and Iron oxide 1g Sang e jarahat-Hydrated Magnesium Silicate 1g All the above three ingredients will be
Sponsors
Govt Unani Medical College Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1.Married and sexually active women of age group 20-45 yrs 2.Study participants having any of the symptoms like vaginal discharge, low backache, lower abdominal pain, dyspareunia, inter menstrual bleeding/spotting, post coital bleeding/spotting 3.All study participants having clinical features of cervicitis and cervical ectopy on per speculum examination 4.Inflammatory Pap smear
Exclusion criteria
Exclusion criteria: 1.Study participants with PID, UTI, STDs, uncontrolled DM,RBS more than 200 mg per dl 2.Study participants with malignancies 3.Participants on OCPs and IUCDs in the last three months 4.Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in symptoms like vaginal discharge, postcoital bleeding, inter-menstrual bleeding, dyspareunia, pelvic pain, backache assessed by VAS scoreTimepoint: Baseline,7th to 10th day,14th to 18th day,30th to 34th day | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Changes in Pap smear 2.Healing of cervical ectopy assessed by cervical ectopy grading scale 3.PSQ 18 4.PGAET Physicians Global Assessment of Efficacy to TherapyTimepoint: 1.Changes in Pap smear Baseline & on 30th to 34th day 2.Healing of cervical ectopy assessed by cervical ectopy grading scale Baseline & on 30th to 34th day 3.PSQ 18 on Baseline & on 30th to 34th day 4.PGAET Physicians Global Assessment of Efficacy to Therapy on 30th to 34th day | — |
Countries
India
Contacts
Public ContactDr Aisha Anjum A
Government Unani Medical College and Hospital
Outcome results
None listed